Trial ID (Number; First author; Year of publication): | ||||
Action | ||||
Methods | ||||
Country: | Study setting: | Duration: | Funding: | |
Allocation: | Blindness: | |||
Participants | ||||
Study population (average/increased risk/high risk individuals): | ||||
Number of participants (N): | Number of participants in each group: | Age: | ||
Sex: | Ethnicity | Included: | Excluded: | |
Interventions Evaluated | ||||
Comparators: | ||||
Outcomes: | ||||
Incidence/recurrence of new adenoma: | Incidence of colorectal cancer: | |||
Incidence of adverse events: | Compliance rate: | |||
Drop-outs (reason): | ||||
Outcomes – unable to use –and WHY | ||||
Results: | ||||
Notes: |